MAGED2 and sarcoma: The results indicated that the members of the MAGE family, including MAGEB10, MAGED2, TRO, MAGEH1, MAGEB18, MAGEB6, MAGEB4, MAGEB1, MAGED4B, MAGED1, MAGEB2, and MAGEB3, were significantly overexpressed in sarcoma tissues.